In DME, chronic hyperglycemia generates metabolic changes resulting in an increase in inflammatory cyto- and chemokines such as interleukin 6 (IL-6), IL-8, TNFα, or ICAM-1 which might alter vascular permeability and disrupt the blood-ocular barrier [7]. Here, IL6 is linked to Hyperglycemia.